What Waiving Vaccine Patent Rights Might Mean for Big Pharma | PBS NewsHour

PBS Learning Media
Contributed By
PBS Learning Media
Resource Type
Classroom Material
Keywords
Daily News Lesson Daily NewsHour DNS big pharma Coronavirus Covid pandemic Covid-19 disaster relief government and civics India international affairs invention Joe Biden Lesson Plan patent pharmaceutical companies social studies US Patent and Trademark Office patent rights intellectual property intellectual property rights IP rights vaccines covid corona virus vaccinations pandemic public health public policy pharmaceuticals pharmaceutical industry pharmaceutical development drug development PBS NewsHour Daily News
Subjects
English-Language Arts Health Studies History-Social Science
Grade Levels
Grade 6 Grade 7 Grade 8 Grade 9 Grade 10 Grade 11 Grade 12
Related Resources

What Waiving Vaccine Patent Rights Might Mean for Big Pharma | PBS NewsHour

President Joe Biden has given the initial nod for the U.S. to waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action.

Check out our Daily News Story collection.
Publisher
PBS Learning Media

Unfortunately, we were unable to load the necessary assets to access this site.
Try reloading the page to verify your network is still working.

If the problem persists, please verify that https://cdn.caeducatorstogether.org/ is not blocked by your network firewall. You may need to reach out to your agency's Network/IT support staff to get access.

For any questions or further assistance please contact us at support@onelearningcommunity.com